Literature DB >> 9934825

Tumor necrosis factor-alpha production after esophageal cancer surgery: differences in the response to lipopolysaccharide stimulation among whole blood, pleural effusion cells, and bronchoalveolar lavage fluid cells.

Y Kimura1, Y Yaegashi, N Sato.   

Abstract

The body's defense mechanism in response to stress may appear to be the sum of activation and suppression. We investigated chronological changes in tumor necrosis factor-alpha (TNF-alpha) production by local effusion cells and whole blood of esophageal cancer patients who had undergone radical resection. Whole blood, pleural effusion cells, and bronchoalveolar lavage fluid (BALF) cells were obtained from the 20 patients. Whole blood was stimulated with Escherichia coli (1 microg/ml), Staphylococcus aureus (10 microg/ml), and lipopolysaccharide (LPS) (1 microg/ml), and pleural effusion cells and BALF cells were stimulated with LPS; 24-H incubation and TNF-alpha concentration in supernate was measured by enzyme-linked immunosorbent assay (ELISA). Within 3 h after starting the operation, TNF-alpha production in whole blood was significantly (P < 0.05) decreased compared with preoperative value by each stimulation, and this suppression persisted up to day 3. These reductions in postoperative TNF-alpha production correlated with intraoperative hemorrhage. On the other hand, the LPS-induced release of TNF-alpha into pleural effusion cells and BALF cells were markedly increased during the study period. These results indicate that large quantities of cytokines are produced by a second attack, such as infection, in areas where immunocytes accumulate. We believe that the body reacts to surgical stress in a variety of ways. Circulating blood and immunocytes that accumulate in damaged organs are thought to react very differently to stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934825     DOI: 10.1007/bf02482963

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

Review 1.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

Review 2.  Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation.

Authors:  R C Bone
Journal:  Crit Care Med       Date:  1996-01       Impact factor: 7.598

3.  Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.

Authors:  G Wakabayashi; J A Gelfand; W K Jung; R J Connolly; J F Burke; C A Dinarello
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Pulmonary hypertension and polymorphonuclear leukocyte elastase after esophageal cancer operations.

Authors:  N Sato; K Murakami; K Ishida; K Ikeda; K Saito
Journal:  Ann Thorac Surg       Date:  1991-05       Impact factor: 4.330

5.  Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values.

Authors:  A H Froon; M H Bemelmans; J W Greve; C J van der Linden; W A Buurman
Journal:  Crit Care Med       Date:  1994-05       Impact factor: 7.598

6.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Authors:  C J Fisher; J F Dhainaut; S M Opal; J P Pribble; R A Balk; G J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

Review 7.  Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk.

Authors:  E Borrelli; P Roux-Lombard; G E Grau; E Girardin; B Ricou; J Dayer; P M Suter
Journal:  Crit Care Med       Date:  1996-03       Impact factor: 7.598

8.  Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.

Authors:  E Fischer; K J Van Zee; M A Marano; C S Rock; J S Kenney; D D Poutsiaka; C A Dinarello; S F Lowry; L L Moldawer
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

Review 9.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

10.  Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock.

Authors:  S Endo; K Inada; M Ceska; T Takakuwa; Y Yamada; H Nakae; T Kasai; H Yamashita; K Taki; M Yoshida
Journal:  J Inflamm       Date:  1995
View more
  3 in total

1.  Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery.

Authors:  Stefan Scheingraber; Daniel Dobbert; Peter Schmiedel; Ewald Seliger; Henning Dralle
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Group IIA-soluble phospholipase A2 levels in patients with infections after esophageal cancer surgery.

Authors:  Masaaki Ogawa; Nobuhiro Sato; Shigeatsu Endo; Masahiro Kojika; Yasunori Yaegashi; Yusuke Kimura; Kenichiro Ikeda; Takeshi Iwaya
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Technical variability is greater than biological variability in a microarray experiment but both are outweighed by changes induced by stimulation.

Authors:  Penelope A Bryant; Gordon K Smyth; Roy Robins-Browne; Nigel Curtis
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.